Cargando…
CD34 and CD38 are prognostic biomarkers for acute B lymphoblastic leukemia
CD34 and CD38 proteins are usually used as surface markers to identify HSCs and Leukemic stem cells. However, there have been cases that lacked CD34 or CD38 protein but still had leukemia initiating capacity in B-ALL suggesting the restrictive of these two markers. CD34 and CD38 expression were dete...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5159997/ https://www.ncbi.nlm.nih.gov/pubmed/28018598 http://dx.doi.org/10.1186/s40364-016-0080-5 |